|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 401 to 500 out of 758 for Flt4

<< First    < Previous  |  Next >    Last >>
0.033s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression
GXD Expression
 
Probe: MGI:7713251
Assay Type: Immunohistochemistry
Annotation Date: 2024-08-29
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1635419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:7713281
Age: embryonic day 11.5
Note: Weaker expression in blood vascular endothelial cells.
Specimen Label: 6E
Detected: true
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:7713251
Assay Type: Immunohistochemistry
Annotation Date: 2024-08-29
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1635419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:7713281
Age: embryonic day 11.5
Note: Weaker expression in blood vascular endothelial cells.
Specimen Label: 6E
Detected: true
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:7713251
Assay Type: Immunohistochemistry
Annotation Date: 2024-08-29
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1635419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:7713281
Age: embryonic day 11.5
Note: Weak expression only in blood vascular endothelial cells.
Specimen Label: 6F
Detected: true
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:7713251
Assay Type: Immunohistochemistry
Annotation Date: 2024-08-29
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1635419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:7713281
Age: embryonic day 11.5
Note: Weak expression only in blood vascular endothelial cells.
Specimen Label: 6F
Detected: true
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6285942
Assay Type: RNA in situ
Annotation Date: 2019-04-03
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1611513
Stage: TS13
Assay Id: MGI:6285953
Age: embryonic day 8.5
Specimen Label: E8.5 not shown
Detected: false
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:6385576
Assay Type: Immunohistochemistry
Annotation Date: 2020-01-22
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1760226
Stage: TS26
Assay Id: MGI:6385654
Age: embryonic day 18.5
Image: 3G
Note: No expression in avascular corneal stroma.
Specimen Label: 3G
Detected: false
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6385576
Assay Type: Immunohistochemistry
Annotation Date: 2020-01-22
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1760226
Pattern: Regionally restricted
Stage: TS26
Assay Id: MGI:6385654
Age: embryonic day 18.5
Image: 3H
Note: Expression in ectopic blood vessels penetraging anterior corneal stroma.
Specimen Label: 3H
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6879441
Assay Type: Immunohistochemistry
Annotation Date: 2022-02-23
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3639223
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:6879449
Age: embryonic day 15.5
Image: 3E
Note: Expressed in a network of vessels beneath the back skin.
Specimen Label: 3E
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754028
Pattern: Widespread
Stage: TS28
Assay Id: MGI:4945849
Age: postnatal day 7
Image: g01657 P7
Specimen Label: g01657 P7
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1754028
Pattern: Widespread
Stage: TS28
Assay Id: MGI:4945849
Age: postnatal day 42
Image: g01657 Adult
Specimen Label: g01657 Adult
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:3577324
Assay Type: Immunohistochemistry
Annotation Date: 2006-10-13
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1824922
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:3663462
Age: embryonic day 13.5
Image: 10A, 10G
Note: Expression was detected in the endothelium lining the jugular sac and in hyperplastic vessels in the jugular region.
Specimen Label: 10A, 10G
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:3577324
Assay Type: Immunohistochemistry
Annotation Date: 2006-10-13
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1824922
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:3663462
Age: embryonic day 13.5
Image: 10B, 10H
Note: Expression was detected in the endothelium lining the jugular sac.
Specimen Label: 10B, 10H
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2011-04-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3579320
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4943920
Age: embryonic day 12.5
Image: Spinal Cord HET
Specimen Label: Spinal Cord HET
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2011-04-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3579320
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4943920
Age: embryonic day 12.5
Image: Spinal Cord KO
Note: In the mutant, despite the malformations, the expression present in the vasculature of the ventral spinal cord is not diminished relative to the levels seen in wild type.
Specimen Label: Spinal Cord KO
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3280928
Pattern: Widespread
Stage: TS28
Assay Id: MGI:4945849
Age: postnatal day 7
Image: g01657 P7
Specimen Label: g01657 P7
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3280928
Pattern: Widespread
Stage: TS28
Assay Id: MGI:4945849
Age: postnatal day 42
Image: g01657 Adult
Specimen Label: g01657 Adult
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:5469047
Assay Type: RNA in situ
Annotation Date: 2013-03-18
Strength: Ambiguous
Sex: Not Specified
Emaps: EMAPS:1620119
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:5469049
Age: embryonic day 11.5
Image: 2E
Note: Staining in the arterial endothelia was very weak, if at all.
Specimen Label: 2E
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
   
Assay Type: In situ reporter (knock in)
Annotation Date: 2021-02-18
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1752523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:6507014
Age: embryonic day 15.5
Image: S2A
Specimen Label: S2A
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Assay Type: In situ reporter (knock in)
Annotation Date: 2021-02-18
Strength: Trace
Sex: Not Specified
Emaps: EMAPS:1752523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:6507014
Age: embryonic day 15.5
Image: S2D
Note: Expression in very few structures in peripheral skin.
Specimen Label: S2D
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:6507011
Assay Type: Immunohistochemistry
Annotation Date: 2021-02-18
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1752523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:6507018
Age: embryonic day 15.5
Image: S2E
Specimen Label: S2E
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:6507011
Assay Type: Immunohistochemistry
Annotation Date: 2021-02-18
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1752523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:6507018
Age: embryonic day 15.5
Image: S2F
Specimen Label: S2F
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6507011
Assay Type: Immunohistochemistry
Annotation Date: 2021-02-18
Strength: Trace
Sex: Not Specified
Emaps: EMAPS:1752523
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:6507018
Age: embryonic day 15.5
Image: S2G
Note: Lymphatic vessels were abnormally shaped or reduced in size and thinner. Authors report complete lack of lymphatic vessels in some double-heterozygous embryos.
Specimen Label: S2G
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3266523
Pattern: Widespread
Stage: TS23
Assay Id: MGI:4945849
Age: embryonic day 15.5
Image: g01657 E15.5
Specimen Label: g01657 E15.5
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4945849
Age: embryonic day 15.5
Image: g01657 E15.5
Note: Expression was region specific and scattered.
Specimen Label: g01657 E15.5
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757728
Pattern: Widespread
Stage: TS28
Assay Id: MGI:4945849
Age: postnatal day 7
Image: g01657 P7
Specimen Label: g01657 P7
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:4882873
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757728
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:4945849
Age: postnatal day 42
Image: g01657 Adult
Note: Expression was region specific and scattered.
Specimen Label: g01657 Adult
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5469047
Assay Type: RNA in situ
Annotation Date: 2013-03-18
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1635713
Pattern: Regionally restricted
Stage: TS13
Assay Id: MGI:5469049
Age: embryonic day 8.5
Image: 2B
Note: Expression was detected in the endothelium of the posterior cardinal vein.
Specimen Label: 2B
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:5469047
Assay Type: RNA in situ
Annotation Date: 2013-03-18
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1609813
Pattern: Regionally restricted
Stage: TS13
Assay Id: MGI:5469049
Age: embryonic day 8.5
Image: 2C
Note: Expression was detected in angioblasts of the head mesenchyme.
Specimen Label: 2C
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:6285942
Assay Type: RNA in situ
Annotation Date: 2019-04-03
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1609813
Pattern: Regionally restricted
Stage: TS13
Assay Id: MGI:6285953
Age: embryonic day 8.5
Image: 4B/D
Specimen Label: 4B/D
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:5635426
Assay Type: Immunohistochemistry
Annotation Date: 2015-05-12
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3274828
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:5635435
Age: postnatal adult
Specimen Label: 8J
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6285942
Assay Type: RNA in situ
Annotation Date: 2019-04-03
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3686720
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6285953
Age: embryonic day 12.5
Image: 5B
Note: Expression predominantly in vessel network in jugular area.
Specimen Label: 5B
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6285942
Assay Type: RNA in situ
Annotation Date: 2019-04-03
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3686720
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6285953
Age: embryonic day 12.5
Image: 6F/H
Note: Expression along borders of jugular venous sacs.
Specimen Label: 6F/H
Detected: true
Specimen Num: 5
•
•
•
•
•
GXD Expression
GXD Expression
Probe: MGI:6285942
Assay Type: RNA in situ
Annotation Date: 2019-04-03
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3706820
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6285953
Age: embryonic day 12.5
Image: 5B
Note: Expression in mesenterium and walls of the gut.
Specimen Label: 5B
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2020-07-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3803619
Pattern: Regionally restricted
Stage: TS19
Assay Id: MGI:6437762
Age: embryonic day 11.5
Note: Expression is in lymph sacs near the cardinal vein.
Specimen Label: 1P
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2020-07-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3803619
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:6437762
Age: embryonic day 11.5
Specimen Label: 2A
Detected: true
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2020-07-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3803622
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:6437762
Age: embryonic day 14.5
Note: Expression is in lumenized lymph sacs in the craniofacial region.
Specimen Label: 5I
Detected: true
Specimen Num: 19
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2020-07-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3803620
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6437762
Age: embryonic day 12.5
Note: Expression is in unlumenized lymph sacs in the craniofacial region.
Specimen Label: 5G
Detected: true
Specimen Num: 18
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2020-07-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3803620
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6437762
Age: embryonic day 12.5
Note: Expression is in lymphatic endothelial cells, including individual, aggregated, and forming lymph sacs and lymphatic vessels in the sublingual regions of the mandibular arches.
Specimen Label: 7A
Detected: true
Specimen Num: 20
•
•
•
•
•
GXD Expression
GXD Expression
 
Probe: MGI:4943862
Assay Type: Immunohistochemistry
Annotation Date: 2020-07-06
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3803622
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:6437762
Age: embryonic day 14.5
Note: Expression is in lymphatic endothelial cells, including individual, aggregated, and forming lymph sacs and lymphatic vessels in the sublingual regions of the mandibular arches.
Specimen Label: 7E
Detected: true
Specimen Num: 21
•
•
•
•
•
Publication
- | J:14001
 
First Author: Lyon MF
Year: 1985
Journal: Mouse News Lett
Title: Chylous ascites (Chy) on Chromosome 11
Volume: 72
Pages: 106-7
•
•
•
•
•
Publication
31928974 | J:332090
First Author: Lioux G
Year: 2020
Journal: Dev Cell
Title: A Second Heart Field-Derived Vasculogenic Niche Contributes to Cardiac Lymphatics.
Volume: 52
Issue: 3
Pages: 350-363.e6
•
•
•
•
•
Publication
25772358 | J:228184
     
First Author: Stanczuk L
Year: 2015
Journal: Cell Rep
Title: cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels.
•
•
•
•
•
Publication
33721923 | J:358584
First Author: McCarter AL
Year: 2020
Journal: Lymphology
Title: Bone development and fracture healing is normal in mice that have a defect in the development of the lymphatic system.
Volume: 53
Issue: 4
Pages: 162-171
•
•
•
•
•
Publication
15855638 | J:98465
First Author: Cursiefen C
Year: 2005
Journal: Am J Pathol
Title: Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling.
Volume: 166
Issue: 5
Pages: 1367-77
•
•
•
•
•
Publication
35222798 | J:322708
 
First Author: Bai J
Year: 2022
Journal: Oxid Med Cell Longev
Title: Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms.
Volume: 2022
Pages: 5044046
•
•
•
•
•
Publication
26096340 | J:226195
First Author: Qin TT
Year: 2015
Journal: J Pathol
Title: Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Volume: 237
Issue: 3
Pages: 307-18
•
•
•
•
•
Publication
23476047 | J:197542
First Author: Singh N
Year: 2013
Journal: Blood
Title: Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
Volume: 121
Issue: 20
Pages: 4242-9
•
•
•
•
•
Publication
11592985 | J:72387
First Author: Karkkainen MJ
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: A model for gene therapy of human hereditary lymphedema.
Volume: 98
Issue: 22
Pages: 12677-82
•
•
•
•
•
Publication
23530147 | J:195520
First Author: Platt AM
Year: 2013
Journal: J Immunol
Title: Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia.
Volume: 190
Issue: 9
Pages: 4608-20
•
•
•
•
•
Publication
17535974 | J:125859
First Author: Wirzenius M
Year: 2007
Journal: J Exp Med
Title: Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.
Volume: 204
Issue: 6
Pages: 1431-40
•
•
•
•
•
Publication
29615616 | J:261944
First Author: Zhang Y
Year: 2018
Journal: Nat Commun
Title: Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms.
Volume: 9
Issue: 1
Pages: 1296
•
•
•
•
•
Publication
38587075 | J:352360
 
First Author: Liu Z
Year: 2024
Journal: JCI Insight
Title: Alkali injury-induced pathological lymphangiogenesis in the iris facilitates the infiltration of T cells and ocular inflammation.
Volume: 9
Issue: 7
•
•
•
•
•
Publication
20224550 | J:200377
First Author: Nilsson I
Year: 2010
Journal: EMBO J
Title: VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts.
Volume: 29
Issue: 8
Pages: 1377-88
•
•
•
•
•
Publication
7622047 | J:26842
First Author: Martin HM
Year: 1995
Journal: Gene
Title: Cloning and characterisation of an ovine interleukin-10-encoding cDNA.
Volume: 159
Issue: 2
Pages: 187-91
•
•
•
•
•
Publication
12867434 | J:85660
First Author: Wise LM
Year: 2003
Journal: J Biol Chem
Title: Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens.
Volume: 278
Issue: 39
Pages: 38004-14
•
•
•
•
•
Publication
21273538 | J:171527
First Author: Yuen D
Year: 2011
Journal: Invest Ophthalmol Vis Sci
Title: Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages.
Volume: 52
Issue: 5
Pages: 2593-7
•
•
•
•
•
Publication
21839079 | J:178405
First Author: Coso S
Year: 2011
Journal: Exp Cell Res
Title: Conserved signaling through vascular endothelial growth (VEGF) receptor family members in murine lymphatic endothelial cells.
Volume: 317
Issue: 17
Pages: 2397-407
•
•
•
•
•
Publication
22430738 | J:184054
First Author: Tan KW
Year: 2012
Journal: J Immunol
Title: Expansion of cortical and medullary sinuses restrains lymph node hypertrophy during prolonged inflammation.
Volume: 188
Issue: 8
Pages: 4065-80
•
•
•
•
•
Publication
22761819 | J:187921
First Author: Larrieu-Lahargue F
Year: 2012
Journal: PLoS One
Title: Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis.
Volume: 7
Issue: 6
Pages: e39540
•
•
•
•
•
Publication
28849193 | J:320843
First Author: Park YG
Year: 2017
Journal: Int J Mol Med
Title: Fluid shear stress regulates vascular remodeling via VEGFR-3 activation, although independently of its ligand, VEGF-C, in the uterus during pregnancy.
Volume: 40
Issue: 4
Pages: 1210-1216
•
•
•
•
•
Publication
11279005 | J:69764
First Author: Baldwin ME
Year: 2001
Journal: J Biol Chem
Title: The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man.
Volume: 276
Issue: 22
Pages: 19166-71
•
•
•
•
•
Publication
9794766 | J:50761
First Author: Dumont DJ
Year: 1998
Journal: Science
Title: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3.
Volume: 282
Issue: 5390
Pages: 946-9
•
•
•
•
•
Publication
20697430 | J:177405
First Author: Zhang L
Year: 2010
Journal: Cell Res
Title: VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.
Volume: 20
Issue: 12
Pages: 1319-31
•
•
•
•
•
Publication
9012504 | J:37681
First Author: Kukk E
Year: 1996
Journal: Development
Title: VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.
Volume: 122
Issue: 12
Pages: 3829-37
•
•
•
•
•
Publication
29550364 | J:263031
First Author: Kontarakis Z
Year: 2018
Journal: Dev Biol
Title: Mir-126 is a conserved modulator of lymphatic development.
Volume: 437
Issue: 2
Pages: 120-130
•
•
•
•
•
Publication
25561555 | J:219191
First Author: Zarkada G
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: VEGFR3 does not sustain retinal angiogenesis without VEGFR2.
Volume: 112
Issue: 3
Pages: 761-6
•
•
•
•
•
Publication
20932899 | J:170175
First Author: Kulkarni RM
Year: 2011
Journal: Mech Dev
Title: Lymphatic ontogeny and effect of hypoplasia in developing lung.
Volume: 128
Issue: 1-2
Pages: 29-40
•
•
•
•
•
Publication
30586762 | J:288391
First Author: Ma Z
Year: 2019
Journal: Circulation
Title: Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1.
Volume: 139
Issue: 13
Pages: 1629-1642
•
•
•
•
•
Publication
27066737 | J:235778
 
First Author: Chen WS
Year: 2016
Journal: Nat Commun
Title: Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3.
Volume: 7
Pages: 11302
•
•
•
•
•
Publication
33356387 | J:319644
First Author: Ruan J
Year: 2021
Journal: Arterioscler Thromb Vasc Biol
Title: Novel Myh11 Dual Reporter Mouse Model Provides Definitive Labeling and Identification of Smooth Muscle Cells-Brief Report.
Volume: 41
Issue: 2
Pages: 815-821
•
•
•
•
•
Publication
30518756 | J:267963
First Author: Durré T
Year: 2018
Journal: Nat Commun
Title: uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.
Volume: 9
Issue: 1
Pages: 5178
•
•
•
•
•
Publication
15743836 | J:97571
First Author: Baldwin ME
Year: 2005
Journal: Mol Cell Biol
Title: Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
Volume: 25
Issue: 6
Pages: 2441-9
•
•
•
•
•
Publication
35050301 | J:328254
 
First Author: Karaman S
Year: 2022
Journal: J Exp Med
Title: Interplay of vascular endothelial growth factor receptors in organ-specific vessel maintenance.
Volume: 219
Issue: 3
•
•
•
•
•
Publication
36910472 | J:358602
First Author: Sung DC
Year: 2022
Journal: Nat Cardiovasc Res
Title: Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C-CDH5 inhibition.
Volume: 1
Issue: 11
Pages: 1006-1021
•
•
•
•
•
Publication
33783987 | J:322845
First Author: Lin QY
Year: 2021
Journal: Clin Transl Med
Title: VEGF-C/VEGFR-3 axis protects against pressure-overload induced cardiac dysfunction through regulation of lymphangiogenesis.
Volume: 11
Issue: 3
Pages: e374
•
•
•
•
•
Publication
17287396 | J:124020
First Author: Mishima K
Year: 2007
Journal: Mol Biol Cell
Title: Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.
Volume: 18
Issue: 4
Pages: 1421-9
•
•
•
•
•
Publication
17540175 | J:122866
First Author: Gupta S
Year: 2007
Journal: Cell
Title: Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.
Volume: 129
Issue: 5
Pages: 957-68
•
•
•
•
•
Publication
30420641 | J:268477
First Author: Vuorio T
Year: 2018
Journal: Sci Rep
Title: Downregulation of VEGFR3 signaling alters cardiac lymphatic vessel organization and leads to a higher mortality after acute myocardial infarction.
Volume: 8
Issue: 1
Pages: 16709
•
•
•
•
•
Publication
24723556 | J:222899
First Author: Vuorio T
Year: 2014
Journal: Arterioscler Thromb Vasc Biol
Title: Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis.
Volume: 34
Issue: 6
Pages: 1162-70
•
•
•
•
•
Publication
26459520 | J:234066
First Author: Nurmi H
Year: 2015
Journal: EMBO Mol Med
Title: VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption.
Volume: 7
Issue: 11
Pages: 1418-25
•
•
•
•
•
Publication
29569811 | J:261727
First Author: Gil HJ
Year: 2018
Journal: Genesis
Title: A novel podoplanin-GFPCre mouse strain for gene deletion in lymphatic endothelial cells.
Volume: 56
Issue: 4
Pages: e23102
•
•
•
•
•
Publication
30783017 | J:273366
 
First Author: Suh SH
Year: 2019
Journal: EMBO Rep
Title: Gut microbiota regulates lacteal integrity by inducing VEGF-C in intestinal villus macrophages.
Volume: 20
Issue: 4
•
•
•
•
•
Publication
21765212 | J:218590
First Author: Bazigou E
Year: 2011
Journal: J Clin Invest
Title: Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice.
Volume: 121
Issue: 8
Pages: 2984-92
•
•
•
•
•
Publication
22474390 | J:183610
First Author: Martínez-Corral I
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.
Volume: 109
Issue: 16
Pages: 6223-8
•
•
•
•
•
Publication
34403369 | J:339458
 
First Author: Keller TCS 4th
Year: 2021
Journal: J Clin Invest
Title: Genetic blockade of lymphangiogenesis does not impair cardiac function after myocardial infarction.
Volume: 131
Issue: 20
•
•
•
•
•
Publication
30601868 | J:269444
First Author: Watanabe C
Year: 2019
Journal: PLoS One
Title: Generating Vegfr3 reporter transgenic mouse expressing membrane-tagged Venus for visualization of VEGFR3 expression in vascular and lymphatic endothelial cells.
Volume: 14
Issue: 1
Pages: e0210060
•
•
•
•
•
Publication
28298294 | J:262016
First Author: Heinolainen K
Year: 2017
Journal: Circ Res
Title: VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Volume: 120
Issue: 9
Pages: 1414-1425
•
•
•
•
•
Publication
24357720 | J:212356
First Author: Ichise T
Year: 2014
Journal: J Cell Sci
Title: FGF2-induced Ras-MAPK signalling maintains lymphatic endothelial cell identity by upregulating endothelial-cell-specific gene expression and suppressing TGFβ signalling through Smad2.
Volume: 127
Issue: Pt 4
Pages: 845-57
•
•
•
•
•
Publication
37338522 | J:337003
 
First Author: Sato-Nishiuchi R
Year: 2023
Journal: J Cell Biol
Title: Polydom/SVEP1 binds to Tie1 and promotes migration of lymphatic endothelial cells.
Volume: 222
Issue: 9
•
•
•
•
•
Publication
10887117 | J:63252
First Author: Kubo H
Year: 2000
Journal: Blood
Title: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis.
Volume: 96
Issue: 2
Pages: 546-53
•
•
•
•
•
Publication
36216515 | J:329888
 
First Author: Cioffi S
Year: 2022
Journal: Life Sci Alliance
Title: VEGFR3 modulates brain microvessel branching in a mouse model of 22q11.2 deletion syndrome.
Volume: 5
Issue: 12
•
•
•
•
•
Publication
38820174 | J:351095
 
First Author: Brouillard P
Year: 2024
Journal: J Clin Invest
Title: Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema.
Volume: 134
Issue: 14
•
•
•
•
•
Publication
- | J:14080
 
First Author: Lyon MF
Year: 1986
Journal: Mouse News Lett
Title: Gene order of Chy-vt-Re on Chromosome 11
Volume: 74
Pages: 96
•
•
•
•
•
Publication
20110424 | J:160267
First Author: Uhrin P
Year: 2010
Journal: Blood
Title: Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation.
Volume: 115
Issue: 19
Pages: 3997-4005
•
•
•
•
•
Publication
20042635 | J:158024
First Author: Ray BN
Year: 2010
Journal: Carcinogenesis
Title: ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.
Volume: 31
Issue: 3
Pages: 435-41
•
•
•
•
•
Publication
7596436 | J:26845
First Author: Fong GH
Year: 1995
Journal: Nature
Title: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
Volume: 376
Issue: 6535
Pages: 66-70
•
•
•
•
•
Publication
21909098 | J:175965
First Author: Tammela T
Year: 2011
Journal: Nat Cell Biol
Title: VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.
Volume: 13
Issue: 10
Pages: 1202-13
•
•
•
•
•
Publication
28658220 | J:249306
First Author: Olmeda D
Year: 2017
Journal: Nature
Title: Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Volume: 546
Issue: 7660
Pages: 676-680
•
•
•
•
•
Publication
33299187 | J:299970
First Author: Liu X
Year: 2020
Journal: Nature
Title: Lymphoangiocrine signals promote cardiac growth and repair.
Volume: 588
Issue: 7839
Pages: 705-711
•
•
•
•
•
Publication
25061878 | J:215790
First Author: Aspelund A
Year: 2014
Journal: J Clin Invest
Title: The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
Volume: 124
Issue: 9
Pages: 3975-86
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom